Gabapentin Tablet, Film Coated
Product Images NDC 82009-072

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 82009-072). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Creatinine Clearance (Gabapentin Fig1)

This text appears to be a formula to calculate "Lt" using the age and weight of a individual, along with their creatinine level. However, without more context it is difficult to determine what "Lt" represents or what the purpose of this formula is.*

FDA Label Image

Figure 1. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 1 (Gabapentin Fig2)

The text describes a figure depicting weekly mean pain scores observed in the ITT population for Study 1. The figure includes the names Ek, Do, Tuon, Priod, and Fred, as well as the medication Gabapentin at a dose of 300 mg/day. There is also a baseline score and a placebo treatment represented on the graph.*

FDA Label Image

Figure 2. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 2 (Gabapentin Fig3)

FDA Label Image

Figure 3. Proportion Of Responders (patients With ≥50% Reduction In Pain Score) At Endpoint: Controlled Phn Studies (Gabapentin Fig4)

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Gabapentin Fig5)

This appears to be a table for a study on Aduncive Therapy in patients over 12 years old with partial seizures. It shows the figure expressed as a difference from placebo at various daily doses in milligrams. However, the information provided is incomplete and difficult to interpret without context.*

FDA Label Image

Package Label-principal Display Panel (600 mg (100 Tablets Bottle))

Each tablet contains 600 mg of Gabapentin USP. It is available in a package of 500 tablets. It should be stored between 20°C to 25°C. The medication guide should be provided separately for each patient. Dispensing instructions are only for pharmacists. The manufacturer is APL Health Care Limited and it is produced for Quallent Pharmaceuticals Health LLC. The expiry date of the product is not available.*

FDA Label Image

Package Label-principal Display Panel (800 mg (100 Tablets Bottle))

Gabapentin Tablets, USP containing 800 mg of Gabapentin USP. The usual dosage should be seen in the package insert for full prescribing information. The tablets should be stored at a temperature of 20°C to 25°C (66°F to 77°F) as controlled room temperature. The medication guide should be dispensed separately to each patient by a pharmacist. Manufactured by APL Health Care Limited, Unit-1 in India and distributed by Quallent Pharmaceuticals in Grand Cayman, Cayman Islands. The expiry date and lot number are not readable.*

FDA Label Image

Chemical Structure (Gabapentin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.